abagovomab 16
abciximab 21
abituzumab 10
abrilumab 12
actoxumab 8
adalimumab 9
aducanumab 5
afasevikumab 3
alacizumab_pegol 6
alemtuzumab 19
alirocumab 12
amatuximab 14
andecaliximab 14
anifrolumab 11
anrukinzumab 13
aprutumab 9
aprutumab_ixadotin 9
arcitumomab 10
ascrinvacumab 0
atezolizumab 10
atinumab 10
avelumab 7
basiliximab 14
bavituximab 11
begelomab 11
benralizumab 13
bevacizumab_beta 10
bezlotoxumab 8
bimagrumab 9
bleselumab 5
blinatumomab 16
blosozumab 23
bococizumab 15
brazikumab 12
brentuximab_vedotin 15
briakinumab 12
brodalumab 7
brolucizumab 15
brontictuzumab 18
burosumab 12
cabiralizumab 11
camrelizumab 10
canakinumab 17
cantuzumab_ravtansin 22
carlumab 12
carotuximab 8
cergutuzumab_amunaleukin2 24
cergutuzumab_amunaleukin 24
certolizumab_pegol 16
cetiximab 24
citatuzumab_bogatox 21
cixutumumab 12
clivatuzumab_tetraxetan 10
codrituzumab 18
conatumumab 9
concizumab 14
crenezumab 11
crizanlizumab 14
crotedumab 16
dacetuzumab 20
daclizumab 5
dalotuzumab 18
dapirolizumab_pegol 19
daratumumab 10
dectrekumab 4
demcizumab 18
denosumab 7
depatuxizumab 13
depatuxizumab_mafodotin 13
dezamizumab 9
dinutuximab 23
diridavumab 6
domagrozumab 11
drozitumab 11
duligotuzumab 20
durvalumab 5
dusigitumab 9
efalizumab 28
efungumab 15
eldelumab 10
elezanumab 11
elgemtumab 3
elotuzumab 10
emactuzumab 12
emapalumab 11
emibetuzumab 8
enavatuzumab 19
enfortumab_vedotin 9
enoblituzumab 15
enokizumab 18
enoticumab 13
ensituximab 11
eptinezumab 9
erenumab 7
etaracizumab 12
etrolizumab 18
evinacumab 15
evolocumab 7
farletuzumab 0
fasinumab 13
fezakinumab 10
fibatuzumab 6
ficlatuzumab 18
firivumab 21
flanvotumab 9
fletikumab 14
foralumab 7
foravirumab 12
fremanezumab 24
fresolimumab 10
fulranumab 15
futuximab 10
galcanezumab 10
ganitumab 14
gantenerumab 7
gemetuzumab 15
gemtuzumab2 18
gemtuzumab 8
gevokizumab 15
girentuximab 16
glembatumumab 15
glembatumumab_vedotin 15
guselkumab 14
ibalizumab 17
ibritumomab 13
icrucumab 10
idarucizumab 19
ifabotuzumab 6
imalumab 11
imgatuzumab 12
inclacumab 11
indatuximab_ravtansin 22
indusatumab 9
inebilizumab 13
intetumumab 3
iodine_girentuximab 18
ipilimumab 0
iratumumab 5
isatuximab 16
itolizumab 15
ixekizumab 17
labetuzumab_govitecan 16
lambrolizumab 11
lampalizumab 18
lanadelumab 15
landogrozumab 12
laprituximab 16
lebrikizumab 18
lendalizumab 21
lenzilumab 10
lifastuzumab_vedotin 15
ligelizumab 13
lilotomab 16
lirilumab 16
lodelcizumab 12
lokivetmab 11
lorvotuzumab_mertansin 10
lucatumumab 20
lumretuzumab 11
lupartumab 10
lutikizumab 9
margetuximab 25
milatuzumab 17
mirvetuximab 18
mirvetuximab_soravtansin 18
modotuximab 25
mogamulizumab 17
monalizumab 15
motavizumab 22
moxetumomab_pasudotox 14
namilumab 13
naratuximab 19
naratuximab_emtansin 19
narnatumab 8
navicixizumab2 23
navicixizumab 18
navivumab 11
necitumumab 7
nemolizumab 15
nesvacumab 14
nivolumab 9
obiltoxaximab 12
obinutuzumab 24
ocaratuzumab 13
ofatumumab 11
olaratumab 8
olokizumab 19
omalizumab 15
onartuzumab 20
ontuxizumab 8
opicinumab 13
orticumab 6
otelixizumab 18
oxelumab 7
ozanezumab 14
pamrevlumab 6
panobacumab 16
parsatuzumab 19
pasotuxizumab 16
pateclizumab 9
patritumab 10
pembrolizumab 11
perakizumab 15
pidilizumab 11
pinatuzumab_vedotin 11
plozalizumab 13
pogalizumab 9
polatuzumab_vedotin 17
ponezumab 18
prezalumab 13
pritoxaximab 19
quilizumab 15
racotumomab 18
radretumab 7
ralpancizumab 20
ramucirumab 7
ranevetmab 22
ranibizumab 7
refanezumab 14
remtolumab 10
rilotumumab 11
rinucumab 3
risankizumab 20
rituximab 5
rivabazumab 17
robatumumab 18
roledumab 13
romosozumab 10
rontalizumab 13
rosmantuzumab 10
rozanolixizumab 13
sacituzumab 22
sacituzumab_govitecan 22
samalizumab 15
sapelizumab 17
sarilumab 9
secukinumab 7
seribantumab 13
setoxaximab 26
sifalimumab 6
siltuximab 7
simtuzumab 16
sirukumab 8
solanezumab 21
solitomab 10
stamulumab 11
suptavumab 18
suvizumab 12
tabalumab 3
tadocizumab 4
tamtuvetmab 23
tanezumab 14
tarextumab 8
tavolixizumab 8
telisotuzumab 18
teplizumab 8
tesidolumab 13
tezepelumab 18
tigatuzumab 12
tildrakizumab 14
timolumab 7
tisotumab 9
tosatoxumab 19
tositumomab 10
tralokinumab 16
trastuzumab 24
tregalizumab 18
trevogrumab 7
ublituximab 12
urelumab 10
ustekinumab 20
utomilumab 16
vadastuximab 11
vadastuximab_talirin 11
vandortuzumab_vedotin 12
vantictumab 14
vanucizumab2 10
vanucizumab 8
varlilumab 15
vatelizumab 8
vedolizumab 10
veltuzumab 4
vesencumab 4
vorsetuzumab 18
vorsetuzumab_mafodotin 18
vunakizumab 19
xentuzumab 15
zatuximab 25
